Project Grant R03DK147916
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $824,078 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with a completion date of January 31, 2030. The award funds a comprehensive research initiative titled "From Real-World Evidence to Systems Pharmacology: A Comprehensive Approach to...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $1.57 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through April 30, 2030. The award funds research to elucidate the role of MRP9 (ATP-binding cassette protein encoded by ABCC12) in cholangiocyte metabolism and cholangiopathy...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $771,701 Project Grant award dated June 1, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports basic biomedical research addressing a critical gap in understanding adipose tissue biology and energy metabolism, with specific focus on the role of beige...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $240,978 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 1, 2025, with completion expected by August 31, 2027. This research project will deliver transcriptional, regulatory, and spatial analysis of kidney development changes during mid to late...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a Project Grant award of $808,304 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, obligated on May 21, 2026, with a completion date of February 28, 2030, supports biomedical research investigating the relationship between extracellular vesicle-associated inflammation in...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $625,508 Project Grant to The Regents of the University of Colorado, doing business as University of Colorado-Denver, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective April 1, 2026, through January 31, 2031, supports a randomized crossover trial investigating mechanisms to mitigate cardiometabolic risk in...
- Federal Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $934,242 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 15, 2026 through February 28, 2030. The award supports a retrospective cohort study applying integrative omics technologies to identify mechanistic pathways underlying adverse...
- Federal Project Grant Award Summary The University of Cincinnati, through its Sponsored Research Services Division, received a $337,906 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 22, 2025, with a completion date of July 31, 2028. The award supports feasibility, acceptability, and preliminary Phase II efficacy testing of the...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $851,275 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 15, 2026, with performance through December 31, 2029. The research investigates mechanisms regulating hepatocyte plasticity and the potential for hepatocyte-to-cholangiocyte reprogramming...
- Federal Grant Award Summary Boston Children's Hospital received a Project Grant award of $168,543.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through March 31, 2031. This award supports biomedical research investigating the mechanisms of hypothalamic-pituitary-adrenal (HPA) axis suppression and recovery following long-term glucocorticoid...
Cincinnati Children's Hospital Medical Center received a $121,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 15, 2026, with completion targeted for May 31, 2028. This research project investigates the relationship between circadian phase—the timing of the internal body clock—and functional abdominal pain disorders (FAPD) in adolescents, a condition associated with significant disability and school absenteeism. The grant supports an objective clinical research study measuring circadian phase using dim light melatonin onset (DLMO) biomarkers in adolescent patients with FAPD and healthy controls. Deliverables include data collection establishing circadian phase timing in the patient population and associations between circadian phase and patient-reported abdominal pain, nausea, and functional disability outcomes. This research represents the first study to objectively measure and correlate circadian phase with FAPD symptoms through direct biomarker assessment, with findings intended to identify circadian timing as a malleable and previously overlooked therapeutic intervention target for this chronic pediatric pain condition.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $121.5k | 6/8/26 |